Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$150.1K
258.00 shares
What this filing means
MESA NILDA plans to sell 258.00 shares of UNITED THERAPEUTICS CORP valued at approximately $150.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/12/2026ACC: 0001950047-26-004420
258.00
Shares to sell
$150.1K
Approx. market value
258.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
7/7/2023
258.00Total acquired258.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/7/2023 | Restricted Stock Not Applicable | 258.00 | — |
| Total | 258.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
258.00
Market value
$150.1K
5/12/2026
Total
Units
258.00
Value
$150.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/12/2026 | 258.00 | $150.1K | NASDAQ | Planned |
| Total | 258.00 | $150.1K | ||